Logo image of SSTI

SOUNDTHINKING INC (SSTI) Stock Fundamental Analysis

NASDAQ:SSTI - Nasdaq - US82536T1079 - Common Stock - Currency: USD

14.45  -0.67 (-4.43%)

After market: 14.45 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SSTI. SSTI was compared to 284 industry peers in the Software industry. SSTI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SSTI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SSTI had negative earnings in the past year.
SSTI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SSTI reported negative net income in multiple years.
SSTI had a positive operating cash flow in each of the past 5 years.
SSTI Yearly Net Income VS EBIT VS OCF VS FCFSSTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

1.2 Ratios

SSTI's Return On Assets of -1.03% is in line compared to the rest of the industry. SSTI outperforms 58.33% of its industry peers.
The Return On Equity of SSTI (-1.99%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.03%
ROE -1.99%
ROIC N/A
ROA(3y)-0.96%
ROA(5y)0.39%
ROE(3y)-2.08%
ROE(5y)0.79%
ROIC(3y)N/A
ROIC(5y)N/A
SSTI Yearly ROA, ROE, ROICSSTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

SSTI has a worse Gross Margin (58.89%) than 63.41% of its industry peers.
In the last couple of years the Gross Margin of SSTI has remained more or less at the same level.
SSTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.42%
GM growth 5Y-0.07%
SSTI Yearly Profit, Operating, Gross MarginsSSTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

SSTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SSTI has been increased compared to 1 year ago.
Compared to 5 years ago, SSTI has more shares outstanding
Compared to 1 year ago, SSTI has a worse debt to assets ratio.
SSTI Yearly Shares OutstandingSSTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
SSTI Yearly Total Debt VS Total AssetsSSTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

SSTI has an Altman-Z score of 1.15. This is a bad value and indicates that SSTI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.15, SSTI is not doing good in the industry: 64.49% of the companies in the same industry are doing better.
SSTI has a debt to FCF ratio of 0.23. This is a very positive value and a sign of high solvency as it would only need 0.23 years to pay back of all of its debts.
SSTI has a Debt to FCF ratio of 0.23. This is in the better half of the industry: SSTI outperforms 77.54% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that SSTI is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.05, SSTI perfoms like the industry average, outperforming 56.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.23
Altman-Z 1.15
ROIC/WACCN/A
WACC13.96%
SSTI Yearly LT Debt VS Equity VS FCFSSTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.78 indicates that SSTI may have some problems paying its short term obligations.
The Current ratio of SSTI (0.78) is worse than 84.78% of its industry peers.
SSTI has a Quick Ratio of 0.78. This is a bad value and indicates that SSTI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.78, SSTI is doing worse than 84.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
SSTI Yearly Current Assets VS Current LiabilitesSSTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 80.33% over the past year.
Looking at the last year, SSTI shows a quite strong growth in Revenue. The Revenue has grown by 19.37% in the last year.
The Revenue has been growing by 21.69% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)80.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.67%
Revenue 1Y (TTM)19.37%
Revenue growth 3Y26.57%
Revenue growth 5Y21.69%
Sales Q2Q%9.48%

3.2 Future

The Earnings Per Share is expected to grow by 4.32% on average over the next years.
SSTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.23% yearly.
EPS Next Y-68.67%
EPS Next 2Y3.08%
EPS Next 3Y4.32%
EPS Next 5YN/A
Revenue Next Year13.33%
Revenue Next 2Y7.76%
Revenue Next 3Y5.62%
Revenue Next 5Y12.23%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SSTI Yearly Revenue VS EstimatesSSTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
SSTI Yearly EPS VS EstimatesSSTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

SSTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SSTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SSTI Price Earnings VS Forward Price EarningsSSTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

SSTI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SSTI is cheaper than 78.99% of the companies in the same industry.
SSTI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SSTI is cheaper than 94.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.32
EV/EBITDA 24.5
SSTI Per share dataSSTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.08%
EPS Next 3Y4.32%

More info and screens

0

5. Dividend

5.1 Amount

SSTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOUNDTHINKING INC

NASDAQ:SSTI (2/21/2025, 8:00:01 PM)

After market: 14.45 0 (0%)

14.45

-0.67 (-4.43%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)02-25 2025-02-25/amc
Inst Owners58.4%
Inst Owner Change-97.08%
Ins Owners24.07%
Ins Owner Change-3.55%
Market Cap181.93M
Analysts78.46
Price Target18.97 (31.28%)
Short Float %1.73%
Short Ratio3.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.47%
Min EPS beat(2)-53.43%
Max EPS beat(2)32.5%
EPS beat(4)2
Avg EPS beat(4)63%
Min EPS beat(4)-176.1%
Max EPS beat(4)449.02%
EPS beat(8)2
Avg EPS beat(8)-431.63%
EPS beat(12)3
Avg EPS beat(12)-799.48%
EPS beat(16)4
Avg EPS beat(16)-608.78%
Revenue beat(2)1
Avg Revenue beat(2)1.64%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)4.23%
Revenue beat(4)1
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-2.93%
Max Revenue beat(4)4.23%
Revenue beat(8)1
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.87%
Revenue beat(16)4
Avg Revenue beat(16)-1.67%
PT rev (1m)-9.27%
PT rev (3m)-9.27%
EPS NQ rev (1m)333.92%
EPS NQ rev (3m)145.15%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.74
P/FCF 10.32
P/OCF 7.78
P/B 2.48
P/tB 36.64
EV/EBITDA 24.5
EPS(TTM)-0.12
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)1.4
FCFY9.69%
OCF(TTM)1.86
OCFY12.86%
SpS8.31
BVpS5.82
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.03%
ROE -1.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.89%
FCFM 16.84%
ROA(3y)-0.96%
ROA(5y)0.39%
ROE(3y)-2.08%
ROE(5y)0.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.42%
GM growth 5Y-0.07%
F-Score8
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.23
Debt/EBITDA 0.59
Cap/Depr 56.82%
Cap/Sales 5.51%
Interest Coverage N/A
Cash Conversion 344.78%
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z 1.15
F-Score8
WACC13.96%
ROIC/WACCN/A
Cap/Depr(3y)95.32%
Cap/Depr(5y)91.69%
Cap/Sales(3y)11%
Cap/Sales(5y)10.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.67%
EPS Next Y-68.67%
EPS Next 2Y3.08%
EPS Next 3Y4.32%
EPS Next 5YN/A
Revenue 1Y (TTM)19.37%
Revenue growth 3Y26.57%
Revenue growth 5Y21.69%
Sales Q2Q%9.48%
Revenue Next Year13.33%
Revenue Next 2Y7.76%
Revenue Next 3Y5.62%
Revenue Next 5Y12.23%
EBIT growth 1Y50.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year472.89%
EBIT Next 3Y99.55%
EBIT Next 5Y63.47%
FCF growth 1Y443.92%
FCF growth 3Y-8.29%
FCF growth 5YN/A
OCF growth 1Y61.2%
OCF growth 3Y-0.78%
OCF growth 5YN/A